UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2009, ISBN 0813545315, x, 252
Book
2004, 1st ed., ISBN 1594030510, xvii, 180
Book
Breast (Edinburgh), ISSN 0960-9776, 2016, Volume 30, pp. 73 - 79
Hematology, Oncology and Palliative Medicine | Eribulin | Breast cancer | Cost | Metastases | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Drug Costs | Lung Neoplasms - drug therapy | Multivariate Analysis | Prognosis | Skin Neoplasms - drug therapy | Breast Neoplasms - economics | Ketones - economics | Humans | Middle Aged | Bone Neoplasms - secondary | Antineoplastic Agents - therapeutic use | Liver Neoplasms - economics | Furans - therapeutic use | Skin Neoplasms - economics | Brain Neoplasms - secondary | Neoplasm Metastasis | Brain Neoplasms - economics | Lung Neoplasms - secondary | Aged, 80 and over | Adult | Female | Ketones - therapeutic use | Retrospective Studies | Bone Neoplasms - drug therapy | France | Liver Neoplasms - secondary | Furans - economics | Liver Neoplasms - drug therapy | Proportional Hazards Models | Linear Models | Survival Rate | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Antineoplastic Agents - economics | Breast Neoplasms - pathology | Cost-Benefit Analysis | Skin Neoplasms - secondary | Aged | Bone Neoplasms - economics | Lung Neoplasms - economics | Chemotherapy | Cancer patients | Family medicine | Metastasis | Cancer | Medical care, Cost of | Medical research | Analysis | Medicine, Experimental | Medical records | Medical care | Quality management | Index Medicus
Journal Article
1999, ISBN 9780807065129, xi, 334
Book
2000, Compass series, ISBN 9780309068895, xvi, 392
Book
Value in health, ISSN 1098-3015, 2017, Volume 20, Issue 4, pp. 567 - 576
Internal Medicine | cost-effectiveness | breast cancer | ovarian cancer | BRCA gene testing | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Business & Economics | Health Policy & Services | Science & Technology | DNA Mutational Analysis - economics | Predictive Value of Tests | Prognosis | Breast Neoplasms - economics | Early Detection of Cancer - methods | Humans | Middle Aged | Models, Economic | Genetic Testing - methods | Breast Neoplasms - therapy | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Neoplasms, Glandular and Epithelial - economics | Time Factors | Computer Simulation | Germ-Line Mutation | Adult | Female | Neoplasms, Glandular and Epithelial - diagnosis | Early Detection of Cancer - economics | Quality-Adjusted Life Years | Genetic Predisposition to Disease | Reproducibility of Results | Risk Assessment | Ovarian Neoplasms - diagnosis | Risk Factors | Decision Support Techniques | Neoplasms, Glandular and Epithelial - therapy | United Kingdom | Heredity | BRCA1 Protein - genetics | Health Care Costs | Phenotype | Breast Neoplasms - genetics | Ovarian Neoplasms - economics | Pedigree | Cost-Benefit Analysis | Carcinoma, Ovarian Epithelial | Ovarian Neoplasms - therapy | Aged | Biomarkers, Tumor - genetics | Breast Neoplasms - diagnosis | Genetic Testing - economics | BRCA2 Protein - genetics | BRCA2 protein | Women | Sensitivity analysis | Parameters | BRCA1 protein | Ovariectomy | Mortality | Breast cancer | Ovarian cancer | Sensitivity | Health economics | Womens health | Oophorectomy | Surgery | Mastectomy | Genetic testing | Mutation | Cost analysis | Willingness to pay | Quality adjusted life years | Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 09/2008, Volume 8, Issue 1, pp. 271 - 271
Life Sciences & Biomedicine | Oncology | Science & Technology | Melanoma - epidemiology | Age Factors | Lung Neoplasms - mortality | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Income | England | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Incidence | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Uterine Cervical Neoplasms - mortality | Breast Neoplasms - epidemiology | Skin Neoplasms - pathology | Papillomavirus Infections - epidemiology | Risk Factors | Melanoma - pathology | Papillomavirus Infections - mortality | Skin Neoplasms - epidemiology | Social Class | Lung Neoplasms - epidemiology | Breast Neoplasms - pathology | Sunlight | Breast Neoplasms - mortality | Aged | Neoplasm Staging | Melanoma - mortality | Smoking | Prevention | Social classes | Research | Health aspects | Risk factors | Public health | Cancer | Index Medicus
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 2013, Volume 22, Issue 5, pp. 616 - 627
Hematology, Oncology and Palliative Medicine | Resource allocations | Palliative care | Site-specific metastasis | Metastatic breast cancer | Supportive care | Low- and middle-income countries | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Spirituality | Bone Neoplasms - therapy | Breast Neoplasms - economics | Humans | Pain Management | Bone Neoplasms - secondary | Palliative Care | Terminal Care - psychology | Liver Neoplasms - therapy | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasm Metastasis | Lung Neoplasms - secondary | Resource Allocation | Female | Liver Neoplasms - secondary | Patient Education as Topic | Skin Neoplasms - therapy | Intestinal Obstruction - therapy | Lung Neoplasms - therapy | Breast Neoplasms - pathology | Breast Neoplasms - psychology | Health Personnel - education | Brain Neoplasms - therapy | Skin Neoplasms - secondary | Developing Countries | Breast cancer | Palliative treatment | Metastasis | Resource allocation | Index Medicus | low- and middle-income countries | palliative care | resource allocations | supportive care | site-specific metastasis | metastatic breast cancer
Journal Article
IARC scientific publications, ISSN 0300-5038, 1997, Issue 138, pp. 65 - 176
Melanoma - epidemiology | Digestive System Neoplasms - mortality | Lung Neoplasms - mortality | Wales - epidemiology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Male | Ovarian Neoplasms - mortality | Liver Neoplasms - mortality | Respiratory Tract Neoplasms - epidemiology | Respiratory Tract Neoplasms - mortality | Socioeconomic Factors | Liver Neoplasms - epidemiology | Skin Neoplasms - mortality | England - epidemiology | Adult | Female | Brain Neoplasms - mortality | Uterine Cervical Neoplasms - mortality | Breast Neoplasms - epidemiology | Latin America - epidemiology | Digestive System Neoplasms - epidemiology | Neoplasms - mortality | Laryngeal Neoplasms - epidemiology | Survival Rate | Mouth Neoplasms - mortality | Skin Neoplasms - epidemiology | Social Class | Ovarian Neoplasms - epidemiology | Mouth Neoplasms - epidemiology | Lung Neoplasms - epidemiology | Laryngeal Neoplasms - mortality | Adolescent | Sex Factors | Breast Neoplasms - mortality | Aged | Longitudinal Studies | Neoplasms - epidemiology | Brain Neoplasms - epidemiology | Melanoma - mortality
Journal Article
JAMA oncology, ISSN 2374-2437, 01/2018, Volume 4, Issue 1, pp. 128 - 129
Life Sciences & Biomedicine | Oncology | Science & Technology | United States - epidemiology | Early Detection of Cancer - trends | Breast Neoplasms - economics | Early Detection of Cancer - methods | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Male | Uterine Cervical Neoplasms - pathology | Colorectal Neoplasms - diagnosis | Incidence | Young Adult | Aged, 80 and over | Uterine Cervical Neoplasms - economics | Adult | Female | Early Detection of Cancer - statistics & numerical data | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Early Detection of Cancer - economics | Uterine Cervical Neoplasms - diagnosis | Patient Protection and Affordable Care Act - economics | Colorectal Neoplasms - economics | Breast Neoplasms - pathology | Aged | Breast Neoplasms - diagnosis | Colorectal Neoplasms - pathology | Neoplasm Staging | Patient Protection and Affordable Care Act - statistics & numerical data
Journal Article
The oncologist (Dayton, Ohio), ISSN 1083-7159, 08/2017, Volume 22, Issue 8, pp. 951 - 962
Health care costs | Metastatic | Outcomes assessment | Immunotherapy | Ipilimumab | Melanoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Melanoma - epidemiology | Skin Neoplasms - pathology | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Melanoma - pathology | Skin Neoplasms - epidemiology | Neoplasms, Second Primary - economics | Neoplasms, Second Primary - epidemiology | Disease-Free Survival | Skin Neoplasms - economics | Health Care Costs | Neoplasm Metastasis | Ipilimumab - economics | Ipilimumab - therapeutic use | Melanoma - drug therapy | Melanoma - economics | Adult | Female | Neoplasms, Second Primary - drug therapy | Neoplasms, Second Primary - pathology | Hospitalization - economics | Index Medicus | Health Outcomes and Economics of Cancer Care
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 04/2020, Volume 129, pp. 60 - 70
Real life | Metastatic breast cancer | Subtypes | Overall survival | HER2 | Life Sciences & Biomedicine | Oncology | Science & Technology | Bone Neoplasms - mortality | Abdominal Neoplasms - secondary | Receptors, Estrogen - metabolism | Prognosis | Age Factors | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Bone Neoplasms - secondary | Receptors, Estrogen - analysis | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Young Adult | Receptors, Progesterone - analysis | Brain Neoplasms - secondary | Skin Neoplasms - prevention & control | Skin Neoplasms - mortality | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Breast - pathology | France - epidemiology | Kaplan-Meier Estimate | Lymphatic Metastasis | Brain Neoplasms - prevention & control | Disease-Free Survival | Bone Neoplasms - prevention & control | Breast Neoplasms - pathology | Abdominal Neoplasms - mortality | Abdominal Neoplasms - prevention & control | Progression-Free Survival | Adolescent | Skin Neoplasms - secondary | Breast Neoplasms - mortality | Aged | Receptor, ErbB-2 - analysis | Confidence intervals | Medical prognosis | Breast cancer | Metastasis | Epidemiology | Survival | Patients | ErbB-2 protein | Subgroups | Tumors | Metastases | Index Medicus | Life Sciences | Cancer
Journal Article